2320253

Source:http://linkedlifedata.com/resource/pubmed/id/2320253

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0013384, umls-concept:C0036055, umls-concept:C0289932
pubmed:issue	4
pubmed:dateCreated	1990-5-7
pubmed:abstractText	Systemic administration of CCK-8S (1 or 10 micrograms/kg IP) markedly inhibited L-dopa-induced dyskinesias in parkinsonian monkeys, but did not interfere with locomotor stimulation by L-dopa. CCK analogues may be useful antidyskinetic agents for improved control of Parkinson's disease.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0401060
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/1-Methyl-4-phenyl-1,2,3,6-tetrahydro..., http://linkedlifedata.com/resource/pubmed/chemical/Levodopa, http://linkedlifedata.com/resource/pubmed/chemical/Sincalide
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	0028-3878
pubmed:author	pubmed-author:BoyceSS, pubmed-author:IversenS DSD, pubmed-author:RupniakN MNM, pubmed-author:SteventonMM
pubmed:issnType	Print
pubmed:volume	40
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	717-8
pubmed:dateRevised	2003-11-14
pubmed:meshHeading	pubmed-meshheading:2320253-1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine, pubmed-meshheading:2320253-Animals, pubmed-meshheading:2320253-Disease Models, Animal, pubmed-meshheading:2320253-Dyskinesia, Drug-Induced, pubmed-meshheading:2320253-Levodopa, pubmed-meshheading:2320253-Parkinson Disease, Secondary, pubmed-meshheading:2320253-Saimiri, pubmed-meshheading:2320253-Sincalide
pubmed:year	1990
pubmed:articleTitle	CCK-8S inhibits L-dopa-induced dyskinesias in parkinsonian squirrel monkeys.
pubmed:affiliation	Merck Sharp & Dohme Research Laboratories, Neuroscience Research Centre, Harlow, Essex, UK.
pubmed:publicationType	Journal Article